Richard Weaver will be joining one of the panel discussions at this year’s Pharma Integrates Conference which takes place in London on the 18 – 19 November 2019.
Pharma Integrates brings together key industry leaders across the pharmaceutical pipeline to share insights and create debate on crucial topics that influence the future of patient outcomes.
Richard will be joining the panel called: Size matters – out with the small molecules? The panel session will take into account ‘growth’ and ‘investment in capabilities’ and look at the future of large molecules versus the future of small molecules, and what the implications are for CDMOs.
The two-day event takes place at the Leonardo Royal Hotel London Tower Bridge. For more information and to register, visit the website.